A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib.
Posted by rob on August 25, 2010 under Uncategorized | 
Comments are off for this article
 |
Related Articles |
A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib.
Leuk Res. 2010 Sep;34(9):e240-2
Authors: Cea M, Cirmena G, Garuti A, Rocco I, Palermo C, Cagnetta A, Moran E, Colombo N, Grasso R, Fugazza G, Gobbi M, Nencioni A, Ballestrero A, Patrone F
PMID: 20447687 [PubMed - indexed for MEDLINE]